Bacteriophage compositions for treating Pseudomonas infection
AssigneeArmata Pharmaceuticals, Inc.
InventorsSebastien Lemire, Stacey Lynn Kolar, Brian C. Varnum, Sandra P. Morales
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to bacteriophages and compositions capable of infecting and killing Pseudomonas, and use of the same for treating Pseudomonas, e.g. Pseudomonas aeruginosa, bacterial infections.
Claims21
A method of treating a bacterial infection comprising administering a composition comprising a bacteriophage comprising a polynucleotide sequence with at least 94% identity to SEQ ID NO:
- 6.
A method of treating a bacterial infection comprising administering a composition comprising two or more bacteriophages comprising a first bacteriophage comprising a polynucleotide sequence with at least 94% identity to SEQ ID NO:
- 6, and one or more additional bacteriophages comprising a polynucleotide sequence with at least 90% identity to SEQ ID NO:
- 1, a polynucleotide sequence with at least 90% identity to SEQ ID NO:
- 3, a polynucleotide sequence with at least 90% identity to SEQ ID NO:
- 4, or a polynucleotide sequence with at least 90% identity to SEQ ID NO:
- 18.
Dependencies are inferred from the claim text.